Acceptability of a Combination Adherence Strategy to Support HIV Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence During Pregnancy and Breastfeeding in Malawi

AIDS Behav. 2023 Dec;27(12):4022-4032. doi: 10.1007/s10461-023-04116-x. Epub 2023 Jul 1.

Abstract

In two parallel pilot studies, we implemented a combination adherence intervention of patient-centered counselling and adherence supporter training, tailored to support HIV treatment (i.e., antiretroviral therapy) or prevention (i.e., pre-exposure prophylaxis, or PrEP) during pregnancy and breastfeeding. Using a mixed-methods approach, we evaluated the intervention's acceptability. We investigated engagement, satisfaction, and discussion content via survey to all 151 participants assigned to the intervention arm (51 women living with HIV, 100 PrEP-eligible women without HIV). We also conducted serial in-depth interviews with a subgroup (n = 40) at enrollment, three months, and six months. In the quantitative analysis, the vast majority reported high satisfaction with intervention components and expressed desire to receive it in the future, if made available. These findings were supported in the qualitative analysis, with favorable comments about counselor engagement, intervention content and types of support received from adherence supporters. Overall, these results demonstrate high acceptability and provide support for HIV status-neutral interventions for antiretroviral adherence.

Keywords: Antiretroviral drugs; HIV; Mixed methods; Pre-exposure prophylaxis; Pregnancy and breastfeeding.

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Breast Feeding
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • Humans
  • Malawi / epidemiology
  • Pre-Exposure Prophylaxis* / methods
  • Pregnancy

Substances

  • Anti-Retroviral Agents